Biodexa Pharmaceuticals Plc ADR (BDRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 861 | 2,587 | 9,792 | 9,383 | 2,102 |
| Cost of Goods | N/A | N/A | 1,193 | 904 | 107 |
| Gross Profit | 861 | 2,587 | 8,599 | 8,479 | 1,995 |
| Operating Expenses | 15,313 | 18,358 | 31,447 | 50,836 | 21,854 |
| Operating Income | -14,452 | -15,771 | -22,655 | -41,453 | -19,752 |
| Interest Expense | 124 | 784 | 214 | 99 | 8 |
| Other Income | 628 | 3 | 535 | 1,812 | 2,586 |
| Pre-tax Income | -13,948 | -16,552 | -22,334 | -39,740 | -17,174 |
| Income Tax | -2,279 | -2,712 | -1,630 | -12,415 | -1,732 |
| Net Income Continuous | -11,668 | -13,839 | -20,703 | -27,326 | -15,441 |
| Net Income Discontinuous | -1,209 | -6,223 | N/A | N/A | N/A |
| Net Income | $-12,878 | $-20,062 | $-20,703 | $-27,326 | $-15,441 |
| EPS Basic Total Ops | -3.51 | -6.56 | -0.80 | -1.52 | -1.10 |
| EPS Basic Continuous Ops | -3.18 | -4.53 | -0.81 | -1.52 | -1.09 |
| EPS Basic Discontinuous Ops | -0.33 | -2.04 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -3.51 | -6.56 | -0.80 | -1.52 | -1.10 |
| EPS Diluted Continuous Ops | -3.18 | -4.53 | -0.81 | -1.52 | -1.09 |
| EPS Diluted Discontinuous Ops | -0.33 | -2.04 | N/A | N/A | N/A |
| EBITDA(a) | $-12,811 | $-13,835 | $-19,355 | $-35,551 | $-18,625 |